BIREN TECH (06082): Wen ZHANG, Zhou HONG, Xiao Bing, and Luting PAN were elected as executive directors of the second board of directors.
Wall Ren Technology (06082) announced that on June 15, 2026, (i) Mr. Wen ZHANG, Mr. Zhou HONG, Mr. Xiao Bing, and Mr. Luting PAN were elected as executive directors of the second board of directors; (ii) Mr. Liu Jingguo was elected as a non-executive director of the second board of directors; and (iii) Mr. Lin Zhaorong, Ms. Liu Jin, and Dr. Yu Zhiyi were elected as independent non-executive directors of the second board of directors. Employee representative director Mr. Linglan ZHANG also serves as an executive director of the company and as a member of the second board of directors. The board of directors has resolved to elect the members of the various committees of the second board of directors.
BIREN TECH (06082) announced on June 15, 2026, that (i) Mr. Wen ZHANG, Mr. Zhou HONG, Mr. Xiao BING, and Mr. Luting PAN were elected as executive directors of the second board of directors; (ii) Mr. Liu Jingguo was elected as a non-executive director of the second board of directors; and (iii) Mr. Lin Zhaorong, Ms. Liu Jin, and Dr. Yu Zhiyi were elected as independent non-executive directors of the second board of directors. Employee representative director Mr. Linglan ZHANG serves as an executive director of the company and is also a member of the second board of directors. The board of directors has resolved to elect the members of the various committees of the second board of directors.
The board of directors has resolved that the Audit Committee of the second board of directors will be composed of Mr. Lin Zhaorong, Ms. Liu Jin, and Dr. Yu Zhiyi. Mr. Lin Zhaorong will serve as chairman of the Audit Committee.
The board of directors has resolved that the Compensation Committee of the second board of directors will be composed of Mr. Wen ZHANG, Ms. Liu Jin, and Dr. Yu Zhiyi. Ms. Liu Jin will serve as the chairman of the Compensation Committee.
The board of directors has resolved that the Nominating Committee of the second board of directors will be composed of Mr. Wen ZHANG, Ms. Liu Jin, and Dr. Yu Zhiyi. Mr. Wen ZHANG will serve as the chairman of the Nominating Committee.
Related Articles

New stock news | Din Tai Pharmaceuticals once again submits an application to the Hong Kong Stock Exchange, becoming the largest CRO in the field of non-clinical research for Chinese cardiovascular and metabolic diseases.

EVEREST MED (01952) has been granted exclusive rights by Dimerix to develop and commercialize DMX-200 in Greater China, South Korea, and several Southeast Asian countries.

New Stock News | Lico Pharmaceuticals files second application to Hong Kong Stock Exchange for the development of small molecule inhibitors for the treatment of autoimmune and inflammatory diseases.
New stock news | Din Tai Pharmaceuticals once again submits an application to the Hong Kong Stock Exchange, becoming the largest CRO in the field of non-clinical research for Chinese cardiovascular and metabolic diseases.

EVEREST MED (01952) has been granted exclusive rights by Dimerix to develop and commercialize DMX-200 in Greater China, South Korea, and several Southeast Asian countries.

New Stock News | Lico Pharmaceuticals files second application to Hong Kong Stock Exchange for the development of small molecule inhibitors for the treatment of autoimmune and inflammatory diseases.

RECOMMEND





